Tissue-Anchored vs. Circulating Engineered Enzyme Constructs for Immunometabolic Resolution of Psoriasis
- Institution
- University of Florida, FL
- Principal investigator
- Benjamin George Keselowsky
- Funding
- $741K
- Duration
- 2023–2028
Moonbase score
Still being scored
Abstract
Project Summary/Abstract We have developed innovative new approaches of administering immunotherapeutic enzymes that robustly directs immune cells away from chronic inflammation toward homeostasis through metabolic programming. Innovative fusion protein enzyme constructs in both tissue-anchored and circulating forms are investigated, quantifying cellular mechanisms of action in order to determine if different administration routes offer advantages. There is considerable need for new therapeutic options for the chronic auto-inflammatory disease, psoriasis, which irreversibly damage epidermal tissues.
Research team
- Dorina AvramPI
- Benjamin George KeselowskyPI
LOADING MOONBASE SCORE
Questions for University of Florida
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · Gordon Research ConferencesNot yet scored
2025 Biomaterials and Tissue Engineering Gordon Research Conference and Seminar
Benjamin George Keselowsky · $10K · 2025–2026
- NIH · University of FloridaNot yet scored
Directing Tryptophan Immunometabolism to Ameliorate Liver Ischemic-Reperfusion Injury
Benjamin George Keselowsky · $569K · 2022–2025
- NIH · University of ArizonaNot yet scored
High throughput screening assays to identify chemical probes targeting Hectd3, an E3 ubiquitin ligase implicated in multiple sclerosis
Dorina Avram · $764K · 2021–2027